PEDIARIX: clinical trials

Sylvia H Yeh1

  • 1UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute at Harbor-UCLA, 1124 W. Carson St, Liu Research Building, Torrance, CA 90502, USA. syeh@uclacvr.labiomed.org

Insights

PEDIARIX is the first pentavalent vaccine in the USA, offering protection against five diseases. This review examines its immunogenicity and safety data in infants.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Immunology

Background:

  • PEDIARIX is the first licensed pentavalent combination vaccine for infants in the USA.
  • It provides protection against diphtheria, tetanus, pertussis, hepatitis B, and poliovirus.

Purpose of the Study:

  • To review available data on the immunogenicity of PEDIARIX.
  • To review available data on the safety of PEDIARIX.

Main Methods:

  • Literature review of published and unpublished studies.
  • Analysis of clinical trial data.
  • Safety surveillance data review.

Main Results:

  • PEDIARIX demonstrated robust immunogenicity against all five antigens.
  • The safety profile of PEDIARIX was found to be acceptable.
  • Common adverse events were generally mild and transient.

Conclusions:

  • PEDIARIX is an effective and safe vaccine for infant immunization.
  • The pentavalent combination vaccine simplifies the infant immunization schedule.
  • Continued surveillance is important to monitor long-term safety and effectiveness.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...